Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00051312.xml
Download PDF
CC BY 4.0 · Avicenna J Med 2023; 13(01): 015-022
DOI: 10.1055/s-0042-1760338
DOI: 10.1055/s-0042-1760338
Review Article
COVID-19 Ramifications: A Scientific Approach to Bridge the Existing Gap between COVID Vaccines Hesitancy and Effectiveness
Abstract
The 2019 coronavirus disease (COVID-19) has been a major dilemma all over the world since December 2019. Several types of COVID-19 vaccines were developed for public utilization to halt the widespread of the disease; however, vaccine hesitancy is one major factor that prevents a successful control of this pandemic. This study aimed to summarize the different kinds of available COVID-19 vaccines and their effectiveness, and to assess the associated factors regarding vaccine hesitancy of the general population to bridge the gap existing between the two factors.[1] [3]
Publication History
Article published online:
13 January 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Gómez-Ochoa SA, Franco OH, Rojas LZ. et al. COVID-19 in health-care workers: a living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes. Am J Epidemiol 2021; 190 (01) 161-175 Erratum in: Am J Epidemiol. 2021 Jan 4;190(1):187. PMID: 32870978; PMCID: PMC7499478
- 2 Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ. COVID-19 Systematic Urgent Review Group Effort (SURGE) study authors. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet 2020; 395 (10242): 1973-1987
- 3 Fang X, Li S, Yu H. et al. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging (Albany NY) 2020; 12 (13) 12493-12503
- 4 Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19. updated December 23, 2020. Accessed January 14, 2021, at: https://www.idsociety.org/practice-guideline/covid-19-guideline-diagnostics/
- 5 Zhou X, Cheng Z, Shu D. et al. Characteristics of mortal COVID-19 cases compared to the survivors. Aging (Albany NY) 2020; 12 (24) 24579-24595
- 6 Madewell ZJ, Yang Y, Longini Jr IM, Halloran ME, Dean NE. Household transmission of SARS-CoV-2: a systematic review and meta-analysis. JAMA Netw Open 2020; 3 (12) e2031756
- 7 Patel A, Jernigan DB. 2019-nCoV CDC Response Team. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak - United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (05) 140-146
- 8 Lopez-Leon S, Wegman-Ostrosky T, Perelman C. et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv 2021:2021.01.27.21250617
- 9 Centers for Disease Control and Prevention. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons Under Investigation (PUIs) for Coronavirus Disease 2019 (COVID-19). Accessed October 15, 2020, at: https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html
- 10 Edouard M, Ritchie H, Rodés-Guirao L. et al. Coronavirus Pandemic (COVID-19) 2020 Published online at: https://ourworldindata.org/coronavirus
- 11 Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health 2021; 194: 245-251
- 12
Polack FP,
Thomas SJ,
Kitchin N.
et al.
C4591001 Clinical Trial Group.
Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020; 383
(27) 2603-2615
MissingFormLabel
- 13
Baden LR,
El Sahly HM,
Essink B.
et al;
COVE Study Group.
Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 2021; 384 (05)
403-416
MissingFormLabel
- 14 Thomas SJ, Moreira Jr ED, Kitchin N. et al; C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N Engl J Med 2021; 385 (19) 1761-1773
- 15 Bernal JL, Andrews N, Gower C. et al. Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant. N Engl J Med 2021; 385 (07) 585-594
- 16 Harder T, Külper-Schiek W, Reda S. et al. Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021. Euro Surveill 2021; 26 (41) 2100920
- 17 Francis AI, Ghany S, Gilkes T, Umakanthan S. Review of COVID-19 vaccine subtypes, efficacy and geographical distributions. Postgrad Med J 2022; 98 (1159): 389-394
- 18 Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation 2021; 144 (06) 471-484
- 19 Rosenblum HG, Hadler SC, Moulia D. et al. Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna): update from the Advisory Committee on Immunization Practices - United States, July 2021. MMWR Morb Mortal Wkly Rep 2021; 70 (32) 1094-1099
- 20 Shay DK, Gee J, Su JR. et al. Safety monitoring of the Janssen (Johnson & Johnson) COVID-19 vaccine - United States, March-April 2021. MMWR Morb Mortal Wkly Rep 2021; 70 (18) 680-684
- 21 Jones I, Roy P. Sputnik V COVID-19 vaccine candidate appears safe and effective. Lancet 2021; 397 (10275): 642-643
- 22 Cazzola M, Rogliani P, Mazzeo F, Matera MG. Controversy surrounding the Sputnik V vaccine. Respir Med 2021; 187: 106569
- 23 Nakanishi H, Suzuki M, Maeda H. et al. Differential diagnosis of COVID-19: importance of measuring blood lymphocytes, serum electrolytes, and olfactory and taste functions. Tohoku J Exp Med 2020; 252 (02) 109-119
- 24 Hani C, Trieu NH, Saab I. et al. COVID-19 pneumonia: a review of typical CT findings and differential diagnosis. Diagn Interv Imaging 2020; 101 (05) 263-268
- 25 Yang H, Chi Y, Chen Z. et al. Differential diagnosis and hospital emergency management for Fastlane treatment of central nervous system infection under the COVID-19 epidemic in Changsha, China. Front Neurol 2020; 11: 555202
- 26 Babamahmoodi F, Saeedi M, Alizadeh-Navaei R. et al. Side effects and Immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran. Sci Rep 2021; 11 (01) 21464
- 27 Zu ZY, Jiang MD, Xu PP. et al. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology 2020; 296 (02) E15-E25
- 28 Cappannoli L, Telesca A, Scacciavillani R. et al. A nontrivial differential diagnosis in COVID-19 pandemic: a case report and literary review of amiodarone-induced interstitial pneumonia. Future Cardiol 2021; 17 (06) 991-997
- 29 Bavishi C, Bonow RO, Trivedi V, Abbott JD, Messerli FH, Bhatt DL. Special article - acute myocardial injury in patients hospitalized with COVID-19 infection: a review. Prog Cardiovasc Dis 2020; 63 (05) 682-689
- 30 Parekh M, Donuru A, Balasubramanya R, Kapur S. Review of the chest CT differential diagnosis of ground-glass opacities in the COVID era. Radiology 2020; 297 (03) E289-E302
- 31 Cai C, Peng Y, Shen E. et al. A comprehensive analysis of the efficacy and safety of COVID-19 vaccines. Mol Ther 2021; 29 (09) 2794-2805
- 32 Edwards KM, Orenstein WA. 2021. Covid 19: vaccines to prevent SARS-CoV2 infection. UpToDate. Retrieved: November 25, 2021
- 33 Kow CS, Hasan SS. The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis. Inflammopharmacology 2021; 29 (03) 641-644